TransMedics Group, Inc. (TMDX)
Preserves donor organs outside the body to make more transplants possible.
$76.29+0.03%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-36.7%
The outlook
TMDX is trading near its 52-week lows with analysts leaning bullish overall, supported by an average price target about 48% above current levels. The stock sits mixed relative to its moving averages, suggesting near-term direction remains uncertain. At a trailing P/E of 17, valuation appears modest relative to analyst sentiment.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 9 analysts
Price trendMixed vs its moving averages
52-week range17% of the way from its 52-week low to high
Price targetAvg target +48% vs current price
Analyst price target
~12-month · 9 analysts$112.89average target+48.0% vs now
Now $76.29
Low $80.00High $142.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$2.64B
52-wk high
$156.00
52-wk low
$60.11
50-day avg
$71.39
200-day avg
$109.83
Trailing P/E
17.0